Clinical trial
Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild…
NCT00354666 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00354666 |
|---|---|
| Title | Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma |
| Official title | A Randomised, Double-blind, Placebo-controlled, Dose Ascending Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled GSK159797 Delivered by Dry Powder Inhaler in Mild to Moderate Asthmatic Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GSK159797 |
| Enrollment | 20 |
| Start date | Sep 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Jul 20, 2006 |
| Last update posted | Sep 1, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: